Why the study?
The impact of early nonfatal complications on subsequent mortality and quality of life after contemporary TAVI remains unclear.
Do early nonfatal complications after TAVI increase 1-year mortality or affect quality of life in patients with severe aortic stenosis?
Population
Patients with severe aortic stenosis undergoing TAVI surviving first 30 days in LANDMARK trial
Comparison
Early nonfatal complications within 30 days after TAVI vs no early nonfatal complications
Design
Post-hoc substudy of randomized trial comparing Myval THV series vs contemporary THV series
Follow-up
1 year
Key result
Early nonfatal complications within 30 days after transcatheter aortic valve implantation were independently associated with increased 1-year mortality (HR 2.14) among 30-day survivors.
Authors
Loading...
May warrant closer surveillance after TAVI; observational data leave open whether preventing complications improves survival.
Cohort (n=742)
Open-label
Yes
Do early nonfatal complications after TAVI increase 1-year mortality or affect quality of life in patients with severe aortic stenosis?
Hazard Ratio: 2.14 (95% CI 1.07–4.27)
Absolute Event Rate: 8% vs 3.9%
p-value: p=0.03
Early nonfatal complications after TAVI are associated with higher 1-year mortality but do not appear to impact 1-year quality of life among 30-day survivors.
Tobe et al. (2026) conducted a cohort in Severe aortic stenosis (n=742). Early nonfatal complications vs. No early nonfatal complications was evaluated on All-cause mortality from 30 to 365 days (HR 2.14, 95% CI 1.07-4.27, p=0.03). Early nonfatal complications within 30 days after transcatheter aortic valve implantation were independently associated with increased 1-year mortality (HR 2.14) among 30-day survivors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: